|
|
News Breaks | | | | February 27, 2013 | | 15:21 EDT |  | MNST, GRPN, ANW, PLL, LTD, BOOM, MYL, JCP, CSGP, WES | Companies reporting After the Market Close on Wednesday, February 27
Notable companies reporting after the closing bell on Wednesday include Aegean Marine Petroleum Network (ANW), CoStar Group (CSGP), Dynamic Materials (BOOM), Groupon (GRPN), J C Penney (JCP), Limited Brands (LTD), Monster Beverage (MNST), Mylan (MYL), Pall (PLL), and Western Gas Partners (WES). | |
|
News For ANW;CSGP;BOOM;GRPN;JCP;LTD;MNST;MYL;PLL;WES From The Last 14 Days Check below for free stories on ANW;CSGP;BOOM;GRPN;JCP;LTD;MNST;MYL;PLL;WES the last two weeks. |
|
|
| June 19, 2013 | | 07:51 EDT |  | MYL | EC fines Ranbaxy, others for blocking cheaper drugs, Economic Times reports
 Subscribe for More Information | | | June 18, 2013 | | 16:13 EDT |  | MNST | AMA adopts policy supporting ban of marketing energy drinks to kids
The American Medical Association, or AMA, announced that it voted during its Annual Meeting to adopt several new policies on emerging issues in public health and science. Among the policies adopted was support for a ban of the marketing of high stimulant/caffeine drinks to adolescents under the age of 18. "Energy drinks contain massive and excessive amounts of caffeine that may lead to a host of health problems in young people, including heart problems, and banning companies from marketing these products to adolescents is a common sense action that we can take to protect the health of American kids," said AMA board member Alexander Ding, M.D. The Fly notes that Forbes reported earlier this week that the AMA might endorse such a ban. | | | 15:23 EDT | | MNST | AMA calls for ban on advertising energy drinks to kids, Bloomberg says
Subscribe for More Information | | | 08:36 EDT |  | MYL | Elan shares could be worh $19 in a buyout, says Jefferies
Jefferies raised its price target for shares of Elan (ELN) to $19 from $14, reflecting what it sees as the value of the company in a takeout scenario. The firm says Elan management suggested they would be open to sale in the $15-$20 per share range. Jefferies believes a high taxpaying suitor could pay the upper end of that range, and lists Allergan (AGN), Regeneron (REGN), Vertex (VRTX), Alexion (ALXN), Zoetis (ZTS), Mylan (MYL) and Perrigo (PRGO) as potential acquirers for Elan. Shares of Elan are up 13c to $13.62 in pre-market trading after Royalty Pharma announced that its buyout proposal for the company has expired. | | | June 17, 2013 | | 13:20 EDT | | MYL | Supreme Court rules generic drug makers can be sued over 'pay to delay'
Subscribe for More Information | | | 11:54 EDT | | MYL | Supreme Court ruling a modest negative for generics, says Leerink
Subscribe for More Information | | | 08:36 EDT | | MYL | InSite Vision to join Merck, Pfizer patent suit against Mylan
InSite Vision (INSV) announced that it will join Merck (MRK) and Pfizer (PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals (MYL). Mylan recently filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking to market a generic version of AzaSite before expiration of the patents covering AzaSite and its use. AzaSite is marketed by Merck in the U.S. On May 26, 2011, InSite and Merck filed a similar patent infringement lawsuit against Sandoz. A trial date for the Sandoz ANDA suit has been set for July 11, 2013. The companies have agreed that Merck will take the lead in prosecuting both lawsuits. Each company will be responsible for their own legal costs, with InSite assuming a monitoring role, the company said. | | | 08:08 EDT | | MNST | Monster Beverage weakness on AMA headlines overdone, says Goldman
Goldman believes weakness in Monster Beverage shares following American Medical Association, or AMA, reports that it may endorse a ban on sales and marketing of energy drinks seems overdone. The analyst said the proposal does not contain new information and the AMA requested additional studies to better understand the issue. | | | 07:41 EDT | | GRPN | Groupon seeing early signs of a turnaround, says Morgan Stanley
Subscribe for More Information | | | 05:51 EDT | | GRPN | For Groupon, much more work to do, WSJ reports
Groupon (GRPN) was supposed to be at risk of collapse. Bears growled about its gigantic marketing budget and lack of barriers protecting its business. But then the stock surged 12% Friday after Deutsche Bank (DB) published a report recommending investors buy. Now up almost threefold from its all-time low last November, Groupon has clearly put the biggest fears to rest. Yet, at $7.65, Groupon gets too much credit for a return to peppy growth when it still has much work to do, reports the Wall Street Journal's "Heard on the Street."Reference Link | | | | June 14, 2013 | | 12:57 EDT |  | MNST | Monster Beverage puts active on report AMA may ban energy drinks
Subscribe for More Information | | | 12:45 EDT | | JCP | Stocks with call strike movement; JCP MU
J.C. Penney (JCP) January call option implied volatility increased 2% to 50, Micron (MU) January 16 call option implied volatility increased 2% to 48 according to IVolatility. | | | 12:43 EDT |  | GRPN, MNST | On The Fly: Midday Wrap
Subscribe for More Information | | | 11:22 EDT | | MNST | Monster Beverage down more than 3% after Forbes says AMA may ban energy drinks
Subscribe for More Information | | | 11:21 EDT | | MNST | AMA could endorse ban of 'high energy' drinks, Forbes reports
The American Medical Association may endorse sales and advertising bans of “high-energy/stimulant drinks” to consumers under 18 years old, due to an increase in emergency room visits "linked to the consumption of 'stimulant' drinks," which are made by companies including Monster Beverage (MNST) and PepsiCo (PEP), according to Forbes. Reference Link | | | 11:18 EDT | | MNST | AMA could endorse ban on high-energy drinks, Forbes says
Reference Link | | | 10:10 EDT |  | GRPN | On The Fly: Analyst Upgrade Summary
Subscribe for More Information | | | 09:58 EDT | | GRPN | Groupon rallies after Deutsche ups rating to Buy
Subscribe for More Information | | | 09:53 EDT |  | GRPN | Groupon rises after upgrade, price target bump, levels to watch
The shares are up over 11.38% to $7.64 in the pre-market following an upgrade by Deutsche Bank to Buy, with a $10 price target, up from $6. The firm cited its belief that the company can grow billings as well as improved sentiment concerning the company. Next resistance based on current price is at $8.16. Support is at $7.48. | | | 09:24 EDT | | GRPN | On The Fly: Pre-market Movers
HIGHER: Groupon (GRPN), up 8% following upgrade at Deutsche Bank... SolarCity (SCTY), up 8% following upgraded to Outperform from Neutral at Credit Suisse... Smith & Wesson (SWHC), up 5.4% after earnings pre-announcement, share buyback plan... Elan (ELN), up 7.7% after starting formal sale process. UP AFTER EARNINGS: Restoration Hardware (RH), up 12.5%. LOWER: China Ming Yang Wind Power (MY), down 4% after CFO steps down... Myriad Genetics (MYGN), down another 4.9% after Supreme Court ruling yesterday on gene patents... News Corp. (NWSA), down 1.5% after CFO announces plan to retire following split. | | |
|
|
|
|
|
|
